Cargando…

Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries

BACKGROUND: The amplification of GTP cyclohydrolase 1 (pfgch1) in Plasmodium falciparum has been linked to the upregulation of the pfdhfr and pfdhps genes associated with resistance to the antimalarial drug sulfadoxine-pyrimethamine. During the 1990s and 2000s, sulfadoxine-pyrimethamine was withdraw...

Descripción completa

Detalles Bibliográficos
Autores principales: Srisutham, Suttipat, Madmanee, Wanassanan, Kouhathong, Jindarat, Sutawong, Kreepol, Tripura, Rupam, Peto, Thomas J., van der Pluijm, Rob W., Callery, James J., Dysoley, Lek, Mayxay, Mayfong, Newton, Paul N., Pongvongsa, Tiengkham, Hongvanthong, Bouasy, Day, Nicholas P. J., White, Nicholas J., Dondorp, Arjen M., Imwong, Mallika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757559/
https://www.ncbi.nlm.nih.gov/pubmed/36525403
http://dx.doi.org/10.1371/journal.pone.0278928
_version_ 1784851844921556992
author Srisutham, Suttipat
Madmanee, Wanassanan
Kouhathong, Jindarat
Sutawong, Kreepol
Tripura, Rupam
Peto, Thomas J.
van der Pluijm, Rob W.
Callery, James J.
Dysoley, Lek
Mayxay, Mayfong
Newton, Paul N.
Pongvongsa, Tiengkham
Hongvanthong, Bouasy
Day, Nicholas P. J.
White, Nicholas J.
Dondorp, Arjen M.
Imwong, Mallika
author_facet Srisutham, Suttipat
Madmanee, Wanassanan
Kouhathong, Jindarat
Sutawong, Kreepol
Tripura, Rupam
Peto, Thomas J.
van der Pluijm, Rob W.
Callery, James J.
Dysoley, Lek
Mayxay, Mayfong
Newton, Paul N.
Pongvongsa, Tiengkham
Hongvanthong, Bouasy
Day, Nicholas P. J.
White, Nicholas J.
Dondorp, Arjen M.
Imwong, Mallika
author_sort Srisutham, Suttipat
collection PubMed
description BACKGROUND: The amplification of GTP cyclohydrolase 1 (pfgch1) in Plasmodium falciparum has been linked to the upregulation of the pfdhfr and pfdhps genes associated with resistance to the antimalarial drug sulfadoxine-pyrimethamine. During the 1990s and 2000s, sulfadoxine-pyrimethamine was withdrawn from use as first-line treatment in southeast Asia due to clinical drug resistance. This study assessed the temporal and geographic changes in the prevalence of pfdhfr and pfdhps gene mutations and pfgch1 amplification a decade after sulfadoxine-pyrimethamine had no longer been widely used. METHODS: A total of 536 P. falciparum isolates collected from clinical trials in Thailand, Cambodia, and Lao PDR between 2008 and 2018 were assayed. Single nucleotide polymorphisms of the pfdhfr and pfdhps genes were analyzed using nested PCR and Sanger sequencing. Gene copy number variations of pfgch1 were investigated using real-time polymerase chain reaction assay. RESULTS: Sequences of the pfdhfr and pfdhps genes were obtained from 96% (517/536) and 91% (486/536) of the samples, respectively. There were 59 distinct haplotypes, including single to octuple mutations. The two major haplotypes observed included IRNI-AGEAA (25%) and IRNL-SGKGA (19%). The sextuple mutation IRNL-SGKGA increased markedly over time in several study sites, including Pailin, Preah Vihear, Ratanakiri, and Ubon Ratchathani, whereas IRNI-AGEAA decreased over time in Preah Vihear, Champasak, and Ubon Ratchathani. Octuple mutations were first observed in west Cambodia in 2011 and subsequently in northeast Cambodia, as well as in southern Laos by 2018. Amplification of the pfgch1 gene increased over time across the region, particularly in northeast Thailand close to the border with Laos and Cambodia. CONCLUSION: Despite the fact that SP therapy was discontinued in Thailand, Cambodia, and Laos decades ago, parasites retained the pfdhfr and pfdhps mutations. Numerous haplotypes were found to be prevalent among the parasites. Frequent monitoring of pfdhfr and pfdhps in these areas is required due to the relatively rapid evolution of mutation patterns.
format Online
Article
Text
id pubmed-9757559
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-97575592022-12-17 Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries Srisutham, Suttipat Madmanee, Wanassanan Kouhathong, Jindarat Sutawong, Kreepol Tripura, Rupam Peto, Thomas J. van der Pluijm, Rob W. Callery, James J. Dysoley, Lek Mayxay, Mayfong Newton, Paul N. Pongvongsa, Tiengkham Hongvanthong, Bouasy Day, Nicholas P. J. White, Nicholas J. Dondorp, Arjen M. Imwong, Mallika PLoS One Research Article BACKGROUND: The amplification of GTP cyclohydrolase 1 (pfgch1) in Plasmodium falciparum has been linked to the upregulation of the pfdhfr and pfdhps genes associated with resistance to the antimalarial drug sulfadoxine-pyrimethamine. During the 1990s and 2000s, sulfadoxine-pyrimethamine was withdrawn from use as first-line treatment in southeast Asia due to clinical drug resistance. This study assessed the temporal and geographic changes in the prevalence of pfdhfr and pfdhps gene mutations and pfgch1 amplification a decade after sulfadoxine-pyrimethamine had no longer been widely used. METHODS: A total of 536 P. falciparum isolates collected from clinical trials in Thailand, Cambodia, and Lao PDR between 2008 and 2018 were assayed. Single nucleotide polymorphisms of the pfdhfr and pfdhps genes were analyzed using nested PCR and Sanger sequencing. Gene copy number variations of pfgch1 were investigated using real-time polymerase chain reaction assay. RESULTS: Sequences of the pfdhfr and pfdhps genes were obtained from 96% (517/536) and 91% (486/536) of the samples, respectively. There were 59 distinct haplotypes, including single to octuple mutations. The two major haplotypes observed included IRNI-AGEAA (25%) and IRNL-SGKGA (19%). The sextuple mutation IRNL-SGKGA increased markedly over time in several study sites, including Pailin, Preah Vihear, Ratanakiri, and Ubon Ratchathani, whereas IRNI-AGEAA decreased over time in Preah Vihear, Champasak, and Ubon Ratchathani. Octuple mutations were first observed in west Cambodia in 2011 and subsequently in northeast Cambodia, as well as in southern Laos by 2018. Amplification of the pfgch1 gene increased over time across the region, particularly in northeast Thailand close to the border with Laos and Cambodia. CONCLUSION: Despite the fact that SP therapy was discontinued in Thailand, Cambodia, and Laos decades ago, parasites retained the pfdhfr and pfdhps mutations. Numerous haplotypes were found to be prevalent among the parasites. Frequent monitoring of pfdhfr and pfdhps in these areas is required due to the relatively rapid evolution of mutation patterns. Public Library of Science 2022-12-16 /pmc/articles/PMC9757559/ /pubmed/36525403 http://dx.doi.org/10.1371/journal.pone.0278928 Text en © 2022 Srisutham et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Srisutham, Suttipat
Madmanee, Wanassanan
Kouhathong, Jindarat
Sutawong, Kreepol
Tripura, Rupam
Peto, Thomas J.
van der Pluijm, Rob W.
Callery, James J.
Dysoley, Lek
Mayxay, Mayfong
Newton, Paul N.
Pongvongsa, Tiengkham
Hongvanthong, Bouasy
Day, Nicholas P. J.
White, Nicholas J.
Dondorp, Arjen M.
Imwong, Mallika
Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries
title Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries
title_full Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries
title_fullStr Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries
title_full_unstemmed Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries
title_short Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries
title_sort ten-year persistence and evolution of plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three asian countries
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757559/
https://www.ncbi.nlm.nih.gov/pubmed/36525403
http://dx.doi.org/10.1371/journal.pone.0278928
work_keys_str_mv AT srisuthamsuttipat tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT madmaneewanassanan tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT kouhathongjindarat tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT sutawongkreepol tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT tripurarupam tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT petothomasj tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT vanderpluijmrobw tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT calleryjamesj tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT dysoleylek tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT mayxaymayfong tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT newtonpauln tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT pongvongsatiengkham tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT hongvanthongbouasy tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT daynicholaspj tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT whitenicholasj tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT dondorparjenm tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries
AT imwongmallika tenyearpersistenceandevolutionofplasmodiumfalciparumantifolateandantisulfonamideresistancemarkerspfdhfrandpfdhpsinthreeasiancountries